This Company Now Has the World’s No. 1 Drug. Should You Invest $1,000?

view original post

Eli Lilly and rival drugmaker Novo Nordisk are the leading companies in the GLP-1 space, but others are emerging. Among them is Pfizer; in September that company announced it would acquire Metsera, a …